Put a consequential choice at the centre of the session

I use a development-scale example to examine the assumptions that can disappear behind a simple quantity multiplier. A 50-kilogram result and a proposed 300-kilogram run may share familiar process names while involving different equipment and material conditions. The session follows the question from an engineering plan into an investment discussion, retaining the schedule consequence and the authority of quality colleagues. Participants consider what the next study is intended to establish, what observation would change the proposed route and which claims remain outside its scope. The example does not teach a manufacturing procedure or suggest that one engineering programme establishes commercial validation. It gives leaders from different functions a shared way to discuss what the technical evidence can support. I close by asking when receiving equipment specialists should enter the planning conversation, so an unexamined scale assumption does not become a fixed investment date before anyone has described the uncertainty that matters.

I invite participants to examine a handover that contains all the expected documents but leaves the receiving team unable to explain an important process choice. The exercise asks what the recipient needs to understand, where the supporting observations can be found and which unresolved question should remain visible. We consider the cost of specialist time and the schedule impact of preparing that account properly. The discussion does not replace controlled records with informal conversation. It examines how records, technical explanation and explicit responsibility work together when knowledge moves between sites. Participants practise asking the originating team about a rejected route and identifying when a proposed adjustment would require another assessment. I also address the continuing dependency created when only one expert can explain the history. The intended result is a more precise set of preparation questions for the participant's own circumstances, rather than a universal handover checklist detached from the product and receiving environment.

I compare an 18-million-yuan pilot proposal with a 72-million-yuan larger-line alternative to show why nominal capacity alone cannot determine the next useful investment. The fictional portfolio contains twelve development projects: nine fit the pilot route and three require another path. We examine the case for the larger purchase as well as the selected smaller step, including finance's concern about deferred expenditure. The discussion distinguishes an approved envelope, completed capital cost, operating expenditure and later project work. Participants are asked how a change in project mix might alter their recommendation and what should return for review after approval. I do not present the smaller option as inherently more prudent. Its merit depends on the work it can support and the obligations it leaves behind. The session is designed to help an investment group make those assumptions explicit, so an impressive capacity figure does not crowd out a more useful comparison of development needs and continuing responsibility.

I explore the difficult review in which a candidate has consumed substantial effort but the proposed next stage lacks a sufficiently grounded new question. The session follows the technical recommendation through the financial account, commercial scenario and reassignment of specialists. Past expenditure remains a cost of work done; an unapproved future proposal is not automatically a realised saving. A successor concept needs its own assessment instead of inheriting the stopped candidate's timetable and promised contribution. Participants consider the strongest argument for continuing and what evidence would make that argument persuasive. I discuss why closure still requires attention to records, materials and remaining responsibilities, and why ending a particular route does not declare every future scientific possibility impossible. The concluding exercise asks teams to define continuation questions earlier in their own programmes, before accumulated effort and forecast expectations make a candid decision harder. The examples remain fictional and concern leadership judgement, not clinical or product-development advice.